The 2018 Annual Houston Shock Symposium will take place April 7–8, 2018 at the JW Marriott.

Cardiogenic shock is a life threatening state of decreased cardiac output with evidence of tissue hypoxia and end organ dysfunction in the presence of adequate intravascular volume. Cardiogenic shock is the leading cause of death in acute myocardial infarction (MI), with over 50% mortality rate despite aggressive treatment. The trend in this high mortality rate over the decades has not significantly decreased.

The Houston Shock Symposium will be a dedicated cardiogenic shock symposium that encompasses interventionalists, advanced heart failure cardiologists, cardiothoracic surgeons, cardiac physiologists, cardiologists, and engineers (Faculty). It is our aim to have world renowned experts in this field to share and advance knowledge, expertise, and vision to save lives and reduce shock’s unacceptable high mortality rate.

This two-day symposium will focus on several aspects of this complex physiologic state (Agenda) in a format that allows attendees to actively participate and engage our invited experts in the field.

The targeted audience are general cardiologists, advanced heart failure cardiologists, cardiothoracic surgeons, intensivists, fellows in training, and medical staff interested in the physiology, diagnosis, and management of cardiogenic shock.


Don’t miss an opportunity to get your hands-on training at The Houston Shock Symposium Wet Lab; featuring Impella, TandemHeart and VV/VA ECMO percutaneous support devices. Sign up via email.

Present at the Annual Houston Shock Symposium

We invite you to share with a panel of experts and your peers a case in one of the following categories:

  • Acute myocardial infarction complicated by shock
  • Acute decompensated heart failure
  • Post cardiotomy cardiogenic shock
  • Post LVAD RV Failure
  • Role of percutaneous mechanical circulatory assist device in shock

Houston Shock Symposium Case Submission is now closed.